ARCHIVES

In Brief: FDA Opens Advisory Committee Consideration Of NDAs, Finds Discussion Is Not Inhibited

This article is from The Cancer Letter archive.

Vol. 02 No. 37 | September 10, 1976

Download PDF Visit The Full Archive

Related Articles

Advisory Groups: Nominations Sought For Director’s Consumer Liaision Group

June 13, 1997

“Of Sofas and Chairs” at MD Anderson: Official Seeks Protection from “Losers,” Explains Costly Interior Design Choices

June 7, 2013

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

April 2, 1999

“The Working Group urges NCI to reconsider its current budget to determine whether the 25 percent devoted to the IRP is appropriate.”

July 7, 1995

In Brief: Van Andel Institute to Build Epigenetics Hub

February 28, 2014

NCI RFPs Available. RFAs Available. Program Announcements.

January 14, 2000